FY2024 EPS Estimates for Teladoc Health Lowered by Analyst

Teladoc Health, Inc. (NYSE:TDOC) – Analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Teladoc Health in a research report issued to clients and investors on Wednesday, October 30th. William Blair analyst R. Daniels now forecasts that the health services provider will post earnings per share of ($1.11) for the year, down from their previous forecast of ($0.93). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.18) per share. William Blair also issued estimates for Teladoc Health’s Q4 2024 earnings at ($0.15) EPS, Q1 2025 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.20) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.08) EPS and FY2025 earnings at ($0.71) EPS.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. The firm had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 9.40% and a negative net margin of 37.91%.

Other equities research analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft boosted their target price on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a report on Friday. Truist Financial dropped their target price on Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Royal Bank of Canada boosted their target price on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a report on Wednesday, October 9th. DA Davidson dropped their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Finally, Barclays boosted their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $11.97.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $8.87 on Monday. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66. The business has a 50 day moving average of $8.48 and a two-hundred day moving average of $9.64. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.54. The company has a market cap of $1.52 billion, a P/E ratio of -1.54 and a beta of 0.90.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in TDOC. Allspring Global Investments Holdings LLC raised its position in shares of Teladoc Health by 74.0% during the first quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after buying an additional 8,750 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Teladoc Health by 33.1% during the first quarter. Principal Financial Group Inc. now owns 13,833 shares of the health services provider’s stock worth $209,000 after buying an additional 3,442 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Teladoc Health by 40.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 209,689 shares of the health services provider’s stock valued at $3,166,000 after purchasing an additional 60,780 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Teladoc Health by 188.7% during the first quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock valued at $477,000 after purchasing an additional 20,651 shares during the last quarter. Finally, Capstone Investment Advisors LLC boosted its stake in Teladoc Health by 44.8% in the first quarter. Capstone Investment Advisors LLC now owns 32,196 shares of the health services provider’s stock valued at $486,000 after acquiring an additional 9,968 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Insider Buying and Selling

In other Teladoc Health news, Director Thomas Mckinley acquired 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the acquisition, the director now owns 39,077 shares of the company’s stock, valued at approximately $300,502.13. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Thomas Mckinley purchased 4,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was bought at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the acquisition, the director now directly owns 39,077 shares of the company’s stock, valued at approximately $300,502.13. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now owns 85,767 shares of the company’s stock, valued at $614,091.72. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,051 shares of company stock worth $257,565. Corporate insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.